Actively Recruiting
Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prostate Cancer
Led by Institut Claudius Regaud · Updated on 2025-08-19
36
Participants Needed
1
Research Sites
37 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This trial is a pilot, prospective, single-center study conducted in a population of patients with metastatic breast cancer (whatever the immunohistochemical subtype) or metastatic prostate cancer. The aim of this exploratory study is to compare the sensitivity of three different techniques (CellSearch®, Parsortix® and SmartCatch®) in detecting circulating tumor cells (CTCs). After the patient's agreement, and before starting anti-tumor treatment, a blood sample will be taken using the 3 different CTC detection techniques. Each patient will participate in the study for one day. A total of 36 evaluable patients (18 patients with metastatic breast cancer and 18 patients with metastatic prostate cancer) will be included in this interventional study.
CONDITIONS
Official Title
Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prostate Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient with metastatic breast cancer (any immunohistochemical subtype) or metastatic prostate cancer, eligible for a new treatment line
- No new specific treatment for breast or prostate cancer started at inclusion
- Age 18 years or older and WHO performance status 2 or less
- Affiliated to the Social Security scheme in France
- Signed informed consent before any study procedures
You will not qualify if you...
- Any associated condition that may interfere with study procedures
- Psychological, family, geographical, or social conditions preventing compliance with medical follow-up or study procedures
- Patient deprived of liberty or under legal protection (guardianship or legal protection)
- History of another solid tumor (except carcinoma in situ of the breast or cervix) within 5 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IUCT-O
Toulouse, France
Actively Recruiting
Research Team
F
Florence DALENC
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here